tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market

CNBX Pharmaceuticals (CNBX) Ratios

Compare
122 Followers

CNBX Pharmaceuticals Ratios

CNBX's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, CNBX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
<0.01 0.01 0.09 0.08 1.25
Quick Ratio
<0.01 0.01 0.09 0.11 1.41
Cash Ratio
<0.01 0.01 0.05 0.05 1.09
Solvency Ratio
-0.12 -0.25 -1.41 -1.46 -1.78
Operating Cash Flow Ratio
-0.07 -0.10 -0.04 -0.69 -1.96
Short-Term Operating Cash Flow Coverage
-0.14 -0.19 -0.08 -0.95 -2.86
Net Current Asset Value
$ -2.54M$ -2.48M$ -2.29M$ -2.25M$ 317.80K
Leverage Ratios
Debt-to-Assets Ratio
71.99 41.27 2.69 2.17 0.28
Debt-to-Equity Ratio
-0.53 -0.52 -0.67 -1.08 0.48
Debt-to-Capital Ratio
-1.12 -1.09 -1.99 13.91 0.33
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
>-0.01 -0.01 -0.25 -0.50 1.70
Debt Service Coverage Ratio
-0.21 -0.46 -2.64 -2.03 -2.79
Interest Coverage Ratio
-6.00 -29.73 -793.34 -2.32K -1.09K
Debt to Market Cap
36.21 6.91 9.01 0.42 0.04
Interest Debt Per Share
0.03 0.04 0.15 1.44 0.76
Net Debt to EBITDA
-4.62 -2.10 -0.34 -0.47 0.16
Profitability Margins
Gross Profit Margin
393.31%100.00%100.00%-562.68%0.00%
EBIT Margin
1106.97%-519.70%-904.28%-12423.98%0.00%
EBITDA Margin
1633.13%-463.58%-864.77%-11761.30%0.00%
Operating Profit Margin
1106.96%-448.21%-227.07%-9860.37%0.00%
Pretax Profit Margin
1277.47%-534.31%-904.57%-12428.23%0.00%
Net Profit Margin
1277.47%-534.31%-904.57%-12581.02%0.00%
Continuous Operations Profit Margin
1277.47%-534.31%-904.57%-14661.80%0.00%
Net Income Per EBT
100.00%100.00%100.00%101.23%77.95%
EBT Per EBIT
115.40%119.21%398.36%126.04%122.85%
Return on Assets (ROA)
-1205.75%-2214.57%-743.48%-464.64%-80.87%
Return on Equity (ROE)
8.89%28.02%183.92%230.90%-137.88%
Return on Capital Employed (ROCE)
7.67%23.51%46.17%180.97%-143.98%
Return on Invested Capital (ROIC)
16.24%49.20%138.25%-2365.86%-75.69%
Return on Tangible Assets
-1205.75%-2214.57%-743.48%-464.64%-80.87%
Earnings Yield
-1317.28%-370.59%-2487.81%-90.67%-10.57%
Efficiency Ratios
Receivables Turnover
-3.54 26.19 4.34 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.43 1.24
Inventory Turnover
0.00 0.00 0.00 -2.46 -1.08
Fixed Asset Turnover
0.00 0.00 1.49 0.07 0.00
Asset Turnover
-0.94 4.14 0.82 0.04 0.00
Working Capital Turnover Ratio
<0.01 -0.05 -0.18 -0.03 0.00
Cash Conversion Cycle
-103.18 13.94 84.19 -996.31 -630.92
Days of Sales Outstanding
-103.18 13.94 84.19 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 -148.50 -337.66
Days of Payables Outstanding
0.00 0.00 0.00 847.80 293.26
Operating Cycle
-103.18 13.94 84.19 -148.50 -337.66
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 -0.01 -1.37 -2.16
Free Cash Flow Per Share
>-0.01 >-0.01 -0.01 -1.37 -2.16
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-159.57 -204.24 -112.52K -1.01K -2.64K
Capital Expenditure Coverage Ratio
-159.57 -204.24 -112.52K -1.01K -2.64K
Operating Cash Flow Coverage Ratio
-0.14 -0.19 -0.08 -0.95 -2.86
Operating Cash Flow to Sales Ratio
10.87 -1.88 -0.27 -56.05 0.00
Free Cash Flow Yield
-516.17%-130.89%-75.45%-40.43%-10.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.08 -0.27 -0.04 -1.10 -9.46
Price-to-Sales (P/S) Ratio
-2.11 1.44 0.36 138.76 0.00
Price-to-Book (P/B) Ratio
>-0.01 -0.08 -0.07 -2.55 13.04
Price-to-Free Cash Flow (P/FCF) Ratio
-0.19 -0.76 -1.33 -2.47 -9.44
Price-to-Operating Cash Flow Ratio
-0.09 -0.77 -1.33 -2.48 -9.45
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 <0.01 -0.03 0.42
Price-to-Fair Value
>-0.01 -0.08 -0.07 -2.55 13.04
Enterprise Value Multiple
-4.75 -2.41 -0.38 -1.65 -7.32
Enterprise Value
1.36M 1.46M 1.36M 5.80M 23.03M
EV to EBITDA
-4.75 -2.41 -0.38 -1.65 -7.32
EV to Sales
-77.60 11.20 3.32 193.54 0.00
EV to Free Cash Flow
-7.14 -5.93 -12.11 -3.45 -9.24
EV to Operating Cash Flow
-7.14 -5.96 -12.11 -3.45 -9.24
Tangible Book Value Per Share
-0.06 -0.08 -0.23 -1.34 1.56
Shareholders’ Equity Per Share
-0.06 -0.08 -0.23 -1.34 1.56
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 -0.01 0.22
Revenue Per Share
>-0.01 <0.01 0.05 0.02 0.00
Net Income Per Share
>-0.01 -0.02 -0.42 -3.08 -2.16
Tax Burden
1.00 1.00 1.00 1.01 0.78
Interest Burden
1.15 1.03 1.00 1.00 1.02
Research & Development to Revenue
4.21 1.50 1.05 39.50 0.00
SG&A to Revenue
-15.28 3.99 2.18 58.57 0.00
Stock-Based Compensation to Revenue
-1.99 1.07 0.44 24.33 0.00
Income Quality
0.85 0.35 0.03 0.45 0.78
Currency in USD